Categories: News

Edison Issues Report on 4imprint Group (FOUR)

London, United Kingdom–(Newsfile Corp. – December 6, 2024) – Edison issues report on 4imprint Group (LSE: FOUR)

4imprint is the leading distributor of promotional product in North America, a very large (c $26bn) and highly fragmented market. The group’s core expertise is in the management of its marketing mix, driving new customer recruitment and stimulating existing customers’ spend. The underlying market has been difficult of late, reflecting geopolitical uncertainty and the lack of business confidence. Despite this, 4imprint has held gross margins at 32% and expects to deliver an operating margin in ‘double figures’ for the full year. Our forecasts are finessed (less than 5%) post the recent trading update, with slightly lower revenue and slightly higher margin. The group is inherently highly cash generative and had cash and short-term deposits of $137m at end October, buoying dividend uplift prospects.

Click here to read the full report.

All reports published by Edison are available to download free of charge from its website
www.edisongroup.com

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232757

Staff

Recent Posts

AI Wellness Launches SoCal Fire Relief Initiative to Support Families and First Responders in Southern California

LOS ANGELES, Jan. 11, 2025 /PRNewswire/ -- Demonstrating a commitment to both innovation and compassion,…

3 hours ago

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced…

18 hours ago

Matinas BioPharma Receives NYSE Noncompliance Notice

BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American:…

18 hours ago

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Craig Swandal, experienced medical device manufacturing executive, joins leadership teamALACHUA, Fla. and TAMPA, Fla., Jan.…

18 hours ago

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage…

18 hours ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”),…

18 hours ago